CGAS and viral infectious disease: The potential mechanism underlying this regulation is that m6A modification can promote mRNA nuclear export, stability, and translation of antiviral immune molecules (cGAS, IFI16, and STING), activate the downstream factor IRF3, induce the expression of IFN-β, and thus enhance the host antiviral immune response during the early stage of viral infection.